Evidence map›Paper›PMID 27272449›Full record

ArticleBone marrow transplantation2016

High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis.

M Remberger, G Afram, M Sundin, M Uhlin, K LeBlanc, A Björklund, J Mattsson, P Ljungman

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease.The European journal of health economics : HEPAC : health economics in prevention and care · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M RembergerCenter for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
G AframDepartment of Hematology, Karolinska University Hospital and Division of Hematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
M SundinHematology/Immunology/SCT Section, Astrid Lindgren Children's Hospital, Karolinska University Hospital and Division of Pediatrics, CLINTEC, Stockholm, Sweden.
M UhlinCenter for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
K LeBlancDepartment of Hematology, Karolinska University Hospital and Division of Hematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
A BjörklundDepartment of Hematology, Karolinska University Hospital and Division of Hematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
J MattssonCenter for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
P LjungmanCenter for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SiblingsTissue DonorsAdolescentAdultAgedGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansIncidenceMiddle AgedRisk FactorsSurvival AnalysisYoung Adult

Identifiers

PMID27272449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.